WHO Classification of Tumours Editorial Board. Soft Tissue and Bone Tumours. vol. 3. International Agency for Research on Cancer; 2020.

Burningham Z, Hashibe M, Spector L, Schiffman JD. The Epidemiology of Sarcoma. Clin Sarcoma Res. 2012;2:14.

Article  PubMed  PubMed Central  Google Scholar 

Bacon A, et al. Incidence and survival of soft tissue sarcoma in England between 2013 and 2017, an analysis from the National Cancer Registration and Analysis Service. Int J Cancer. 2023;152:1789–803.

Article  CAS  PubMed  Google Scholar 

Stiller CA, et al. Descriptive epidemiology of sarcomas in Europe: Report from the RARECARE project. Eur J Cancer. 2013;49:684–95.

Article  CAS  PubMed  Google Scholar 

Rothermundt C, et al. What is the role of routine follow-up for localised limb soft tissue sarcomas? A retrospective analysis of 174 patients. Br J Cancer. 2014;110:2420–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cable MG, Randall RL. Extremity Soft Tissue Sarcoma: Tailoring Resection to Histologic Subtype. Surg Oncol Clin N Am. 2016;25:677–95.

Article  PubMed  Google Scholar 

Loong HH, Wong K-H, Tse T. Controversies and consensus of neoadjuvant chemotherapy in soft-tissue sarcomas. ESMO Open. 2018;3(Suppl 1):e000293.

Pasquali S, Gronchi A. Neoadjuvant chemotherapy in soft tissue sarcomas: latest evidence and clinical implications. Ther Adv Med Oncol. 2017;9:415–29.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sarcoma Meta-analysis Collaboration. Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data. The Lancet. 1997;350:1647–54.

Article  Google Scholar 

Pervaiz N, et al. A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma. Cancer. 2008;113:573–81.

Article  PubMed  Google Scholar 

Pasquali S, et al. The impact of chemotherapy on survival of patients with extremity and trunk wall soft tissue sarcoma: revisiting the results of the EORTC-STBSG 62931 randomised trial. Eur J Cancer. 2019;109:51–60.

Article  CAS  PubMed  Google Scholar 

Gronchi A, et al. Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆. Ann Oncol. 2021;32:1348–65.

Article  CAS  PubMed  Google Scholar 

Trojani M, et al. Soft-tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system. Int J Cancer. 1984;33:37–42.

Article  CAS  PubMed  Google Scholar 

Guillou L, et al. Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma. J Clin Oncol Off J Am Soc Clin Oncol. 1997;15:350–62.

Article  CAS  Google Scholar 

Coindre JM, et al. Predictive value of grade for metastasis development in the main histologic types of adult soft tissue sarcomas: a study of 1240 patients from the French Federation of Cancer Centers Sarcoma Group. Cancer. 2001;91:1914–26.

Article  CAS  PubMed  Google Scholar 

Kattan MW, Leung DHY, Brennan MF. Postoperative Nomogram for 12-Year Sarcoma-Specific Death. J Clin Oncol. 2002;20:791–6.

Article  PubMed  Google Scholar 

Iasonos A, Schrag D, Raj GV, Panageas KS. How To Build and Interpret a Nomogram for Cancer Prognosis. J Clin Oncol. 2008;26:1364–70.

Article  PubMed  Google Scholar 

Eilber FC, et al. Validation of the postoperative nomogram for 12-year sarcoma-specific mortality. Cancer. 2004;101:2270–5.

Article  PubMed  Google Scholar 

Ng DWJ, et al. Is the Memorial Sloan Kettering Cancer Centre (MSKCC) sarcoma nomogram useful in an Asian population? Asia Pac J Clin Oncol. 2017;13:e466–72.

Article  PubMed  Google Scholar 

Bagaria SP, et al. Validation of a Soft Tissue Sarcoma Nomogram Using a National Cancer Registry. Ann Surg Oncol. 2015;22(Suppl 3):S398-403.

Article  PubMed  Google Scholar 

Mariani L, et al. Validation and adaptation of a nomogram for predicting the survival of patients with extremity soft tissue sarcoma using a three-grade system. Cancer. 2005;103:402–8.

Article  PubMed  Google Scholar 

Danieli M, Gronchi A. Staging Systems and Nomograms for Soft Tissue Sarcoma. Curr Oncol. 2023;30:3648–71.

Article  PubMed  PubMed Central  Google Scholar 

Pasquali S, et al. The sarculator stratified prognosis of patients with high-risk soft tissue sarcomas (STS) of extremities and trunk wall treated with perioperative chemotherapy in a randomised controlled trial (RCT). J Clin Oncol. 2017;35:11016–11016.

Article  Google Scholar 

Gronchi A, et al. Outcome Prediction in Primary Resected Retroperitoneal Soft Tissue Sarcoma: Histology-Specific Overall Survival and Disease-Free Survival Nomograms Built on Major Sarcoma Center Data Sets. J Clin Oncol. 2013;31:1649–55.

Article  PubMed  Google Scholar 

Callegaro D, et al. New Sarculator Prognostic Nomograms for Patients with Primary Retroperitoneal Sarcoma: Case Volume Does Matter. Ann Surg. 2023. https://doi.org/10.1097/SLA.0000000000006098.

Article  PubMed  Google Scholar 

Callegaro D, et al. Development and external validation of a dynamic prognostic nomogram for primary extremity soft tissue sarcoma survivors. eClinicalMedicine. 2019;17:100215.

Squires MH, et al. Extremity Soft Tissue Sarcoma: A Multi-Institutional Validation of Prognostic Nomograms. Ann Surg Oncol. 2022;29:3291–301.

Article  PubMed  Google Scholar 

Squires MH, et al. A multi-institutional validation study of prognostic nomograms for retroperitoneal sarcoma. J Surg Oncol. 2021;124:829–37.

Article  PubMed  Google Scholar 

Pasquali S, et al. Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: A Sarculator-based risk stratification analysis of the ISG-STS 1001 randomized trial. Cancer. 2022;128:85–93.

Article  CAS  PubMed  Google Scholar 

van Praag VM, et al. A prediction model for treatment decisions in high-grade extremity soft-tissue sarcomas: Personalised sarcoma care (PERSARC). Eur J Cancer. 2017;83:313–23.

Article  PubMed  Google Scholar 

Rueten-Budde AJ, van Praag VM, PERSARC studygroup, van de Sande MaJ, Fiocco M. Dynamic prediction of overall survival for patients with high-grade extremity soft tissue sarcoma. Surg Oncol. 2018;27:695–701.

Rueten-Budde AJ, van Praag VM, van de Sande MAJ, Fiocco M. External validation and adaptation of a dynamic prediction model for patients with high-grade extremity soft tissue sarcoma. J Surg Oncol. 2021;123:1050–6.

Article  PubMed  Google Scholar 

Dalal KM, Kattan MW, Antonescu CR, Brennan MF, Singer S. Subtype Specific Prognostic Nomogram for Patients With Primary Liposarcoma of the Retroperitoneum, Extremity, or Trunk. Ann Surg. 2006;244:381–91.

Article  PubMed  PubMed Central  Google Scholar 

Canter RJ, et al. A Synovial Sarcoma Specific Preoperative Nomogram Supports a Survival Benefit to Ifosfamide-Based Chemotherapy and Improves Risk Stratification for Patients. Clin Cancer Res Off J Am Assoc Cancer Res. 2008;14:8191–7.

Article  CAS  Google Scholar 

Coindre J-M. Grading of Soft Tissue Sarcomas: Review and Update. Arch Pathol Lab Med. 2006;130:1448–53.

Article  PubMed  Google Scholar 

Chibon F, et al. Validated prediction of clinical outcome in sarcomas and multiple types of cancer on the basis of a gene expression signature related to genome complexity. Nat Med. 2010;16:781–7.

Article  CAS  PubMed  Google Scholar 

Merry E, Thway K, Jones RL, Huang PH. Predictive and prognostic transcriptomic biomarkers in soft tissue sarcomas. NPJ Precis Oncol. 2021;5:17.

Article  PubMed  PubMed Central